Attenuation of recombinant vesicular stomatitis viruses encoding mutant glycoproteins demonstrate a critical role for maintaining a high Ph threshold for membrane fusion in viral fitness

Virology

Volumn 240, Issue 2, 1998, Pages 349-358

  Fredericksen, Brenda L ^a   Whitt, Michael A ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHLOROQUINE; VIRUS GLYCOPROTEIN;

AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOSOME; HAMSTER; HUMAN; HUMAN CELL; MEMBRANE FUSION; NONHUMAN; PH; PHENOTYPE; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS; VIRUS INFECTIVITY; VIRUS PLAQUE; VIRUS RECOMBINANT; VIRUS REPLICATION;

ANIMALIA; CRICETINAE; RNA VIRUSES; VESICULAR STOMATITIS VIRUS;

EID: 0032518229     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8921     Document Type: Article

References (40)

1. Alkhatib G., Shen S. H., Briedis D., Richardson C., Massie B., Weinberg R., Smith D., Taylor J., Paoletti E., Roder J. Functional analysis of N-linked glycosylation mutants of the measles virus fusion protein synthesized by recombinant vaccinia virus vectors. J. Virol. 68:1994;1522-1531.
2. Blumenthal R., Bali-Puri A., Walter A., Covell D., Eidelman O. pH-dependent fusion of vesicular stomatitis virus with Vero cells. J. Biol. Chem. 262:1987;13614-13619.
3. Bullough P. A., Hughson F. M., Skehel J. J., Wiley D. C. Structure of influenza haemagglutinin at the pH of membrane fusion. Nature. 371:1994;37-43.
4. Clague M., Schoch C., Zech L., Blumenthal R. Gating kinetics of pH-activated membrane fusion of vesicular stomatitis virus with cells: Stopped-flow measurements by dequenching of octadecylrhodamine fluorescence. Biochemistry. 29:1990;1303-1308.
5. Domingo E., Escarmis C., Sevilla N., Moya A., Elena S. F., Quer J., Novella I. S., Holland J. J. Basic concepts in RNA virus evolution. FASEB J. 10:1996;859-864.
6. Fredericksen B. L., Whitt M. A. Vesicular stomatitis virus glycoprotein mutations that affect membrane fusion activity and abolish virus infectivity. J. Virol. 69:1995;1435-1443.
7. Fredericksen B. L., Whitt M. A. Mutations at two conserved acidic amino acids in the glycoprotein of vesicular stomatitis virus affect pH-dependent conformational changes and reduce the pH threshold for membrane fusion. Virology. 217:1996;49-57.
8. Fuerst T. R., Niles E. G., Studier R. W., Moss B. Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase. Proc. Natl. Acad. Sci. USA. 83:1986;8122-8126.
9. Fuller S. D., Berriman J. A., Butcher S. J., Gowen B. E. Low pH induces swiveling of the glycoprotein heterodimers in the Semliki forest virus spike complex. Cell. 81:1995;715-725.
10. Gaudin Y., Ruigrok R. W., Knossow M., Flamand A. Low-pH conformational changes of rabies virus glycoprotein and their role in membrane fusion. J. Virol. 67:1993;1365-1372.
11. Gaudin Y., Ruigrok R. W., Brunner J. Low-pH induced conformational changes in viral fusion proteins: Implications for the fusion mechanism. J. Gen. Virol. 76:1995a;1541-1556.
12. Gaudin Y., Tuffereau C., Durrer P., Flamand A., Ruigrok R. W. H. Biological function of the low-pH, fusion-inactive conformation of rabies virus glycoprotein (G): G is transported in a fusion-inactive state-like conformation. J. Virol. 69:1995b;5528-5534.
13. Gething M.-J., Doms R. W., York D., White J. Studies on the mechanism of membrane fusion: Site-specific mutagenesis of the hemagglutinin of influenza virus. J. Cell Biol. 102:1986;11-23.
14. Gilbert J. M., Hernandez L. D., Balliet J. W., Bates P., White J. M. Receptor-induced conformational changes in the subgroup A avian leukosis and sarcoma virus envelope glycoprotein. J. Virol. 69:1995;7410-7415.
15. Grambas S., Hay A. J. Maturation of influenza A virus hemagglutinin - Estimates of the pH encountered during transport and its regulation by the M2 protein. Virology. 190:1992;11-18.
16. Helenius. Unpacking the incoming influenza virus. Cell. 69:1992;577-578.
17. Helenius A., Marsh M., White J. Inhibition of Semliki Forest virus penetration by lysosomotropic weak bases. J. Gen. Virol. 58:1982;47-61.
18. Hernandez L. D., Hoffman L. R., Wolfsberg T. G., White J. M. Virus-cell and cell-cell fusion. Annu. Rev. Cell Dev. Biol. 12:1996;627-661.
19. Lawson N., Stillman E., Whitt M. A., Rose J. K. Recombinant vesicular stomatitis viruses from DNA. Proc. Natl. Acad. Sci. USA. 92:1995;4477-4481.
20. Levy-Mintz P., Kielian M. Mutagenesis of the putative fusion domain of the Semliki Forest virus spike protein. J. Virol. 65:1991;4292-4300.
21. Matlin K., Reggio H., Helenius A., Simons K. The pathway of vesicular stomatitis entry leading to infection. J. Mol. Biol. 156:1982;609-631.
22. Miller D., Lenard J. Inhibition of vesicular stomatitis virus infection by spike glycoprotein. J. Cell Biol. 84:1980;430-437.
23. Mulligan M. J., Yamshchikov G. V., Ritter G. Jr., Gao F., Jin M. J., Nail C. D., Spies C. P., Hahn B. H., Compans R. W. Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell types. J. Virol. 66:1992;3971-3975.
24. Philipp H. C., Schroth R., Veit m., Krumbiegel M., Herrmann A., Schmidt M. F. G. Assessment of fusogenic properties of influenza virus hemagglutinin deacylated by site-directed mutagenesis and hydroxylamine treatment. Virology. 210:1995;20-28.
25. Pinto L. H., Holsinger L. J., Lamb R. A. Influenza virus M2 protein has ion channel activity. Cell. 69:1992;517-528.
26. Puri A., Grimaldi S., Blumenthal R. Role of viral envelope sialic acid in membrane fusion mediated by the vesicular stomatitis virus envelope glycoprotein. Biochemistry. 31:1992;10108-10113.
27. Puri A., Winick J., Lowy J. R., Covell D., Eidelman O., Walter A., Blumenthal R. Activation of vesicular stomatitis virus fusion with cells by pretreatment at low pH. J. Biol. Chem. 263:1988;4749-4753.
28. Rey F. A., Heinz F. X., Mandl C., Kunz C., Harrison S. C. The envelope glycoprotein from tick-borne encephalitis virus at 2 A resolution. Nature. 375:1995;291-298.
29. Sattentau Q. J., Moore J. P., Vignaux F., Traincard F., Poignard P. Conformational changes induced in the envelope glycoproteins of the human and simian immunodeficiency viruses by soluble receptor binding. J. Virol. 67:1993;7383-7393.
30. Schmid S., Fuchs R., Kielian M., Helenius A., Mellman I. Acidification of endosome subpopulations in wild-type Chinese hamster ovary cells and temperature-sensitive acidification-defective mutants. J. Cell Biol. 108:1989;1291-1300.
31. Schnell M. J., Mebatsion T., Conzelmann K.-K. Infectious rabies viruses from cloned cDNA. EMBO J. 13:1994;4195-4203.
32. Singh I., Helenius A. Nucleocapsid uncoating during entry of enveloped animal RNA viruses into cells. Sem. Virol. 3:1992;511-518.
33. Steinhauer D. A., Wharton S. A., Skehel J. J., Wiley D. C. Studies of the membrane fusion activities of fusion peptide mutants of influenza virus hemagglutinin. J. Virol. 69:1995;6643-6651.
34. Whelan S. P. J., Ball L. A., Barr J. N., Wertz G. T. W. Efficient recovery of infectious vesicular stomatitis virus entirely from cDNA clones. Proc. Natl. Acad. Sci. USA. 92:1995;8388-8392.
35. White J. M. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:1990;675-697.
36. White J. M. Membrane fusion: The influenza paradigm. Cold Spring Harbor Symp. Quant. Biol. 60:1995;581-588.
37. Whitt M. A., Chong L., Rose J. K. Glycoprotein cytoplasmic domain sequences required for rescue of a vesicular stomatitis virus glycoprotein mutant. J. Virol. 63:1989;3569-3578.
38. Whitt M. A., Zagouras P., Crise B., Rose J. K. A fusion-defective mutant of the vesicular stomatitis virus glycoprotein. J. Virol. 64:1990;4907-4913.
39. Wilson C. A., Marsh J. W., Eiden M. V. The requirements for viral entry differ from those for virally induced syncytium formation in NIH 3T3/DTras cells exposed to moloney murine leukemia virus. J. Virol. 66:1992;7262-7269.
40. Zhang L., Ghosh H. P. Characterization of the putative fusogenic domain in vesicular stomatitis virus glycoprotein G. J. Virol. 68:1994;2186-2193.